Keyphrases
Lymphoma
100%
Prognostic Indicator
100%
Human Leukocyte Antigen
100%
Autologous Transplantation
100%
Non-associated
30%
Cell Dose
30%
Human Leukocyte Antigen Class I
30%
Poor Outcome
20%
Transfusion
20%
Lactate Dehydrogenase
20%
Transplant Outcomes
20%
B Locus
20%
Auto-aggression
20%
Transplantation
10%
Multivariate Analysis
10%
Clinical Setting
10%
Odds Ratio
10%
Natural Killer Cells
10%
Mediated Interaction
10%
Cytolysis
10%
Independent Risk Factors
10%
Autoimmune Disease
10%
Cytokine Release
10%
Progenitor Cells
10%
Increased Incidence
10%
Treatment Toxicity
10%
Graft-versus-host Disease (GvHD)
10%
Lymphoma Patients
10%
Disease Pattern
10%
Inhibitory Activity
10%
Graft Rejection
10%
Elevated Lactate
10%
DR Locus
10%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
10%
Tumor Cytotoxicity
10%
Target Antigen
10%
Nucleated Cells
10%
Disease Association
10%
Early Transplant
10%
New Human Leukocyte Antigen Allele
10%
Natural Killer Cell Receptors
10%
Blood Progenitor
10%
Human Leukocyte antigen-A
10%
Human Leukocyte Antigen Typing
10%
Medicine and Dentistry
Human Leukocyte Antigen
100%
Autotransplantation
100%
Lactate Dehydrogenase
12%
Diseases
12%
Natural Killer Cell
6%
Cytolysis
6%
Autoimmune Disease
6%
Cytokine Release
6%
Cytotoxicity
6%
Retrospective Study
6%
Graft Rejection
6%
Progenitor Cell
6%
Stem Cell Transplant
6%
Disease Association
6%
Transplantation Antigen
6%
Natural Killer Cell Receptor
6%
Antigen Function
6%
Odds Ratio
6%
Multivariate Analysis
6%
Immunology and Microbiology
Human Leukocyte Antigen
100%
Autotransplantation
100%
Natural Killer Cell
12%
Cytolysis
6%
Autoimmune Disease
6%
Cytotoxicity
6%
Cytokine Release
6%
Stem Cell Transplant
6%
Antigen Function
6%
Transplantation Antigen
6%